Oragenics
OGEN
10 hedge funds and large institutions have $350K invested in Oragenics in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
92% more capital invested
Capital invested by funds: $182K → $350K (+$167K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% less ownership
Funds ownership: 0.08% → 0.08% (-0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$7.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.38K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$355 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $125K | – | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $111K | – | – | – |
|
|
3
Renaissance Technologies
New York
| $87K | +$7.46K | +63 | +14% |
|
4
Fidelity Investments
Boston,
Massachusetts
| $14.6K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $10.6K | -$4.38K | -37 | -37% |
|
6
Bank of America
Charlotte,
North Carolina
| $636 | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $186 | -$355 | -3 | -75% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $128 | – | – | – |
|
9
Wells Fargo
San Francisco,
California
| $119 | – | – | – |
|
|
WWM
10
Wolff Wiese Magana
Carslbad,
California
| $96 | – | – | – |
|
11
Morgan Stanley
New York
| $46 | – | – | – |
|
|
CAM
12
Chesapeake Asset Management
New York
| $16 | – | – | – |
|
13
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $6 | – | – | – |
|
|
TFG
14
Team Financial Group
Temecula,
California
| $6 | – | – | – |
|
OGEN Hedge Fund Activity: Q4 2023 in Review
10 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2023, worth a combined $350K — up 92% from $182K a quarter earlier.
Fund positioning in OGEN was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $7.46K. The largest seller was Tower Research Capital (TRC), cutting an estimated $4.38K.
- 10 institutional investors held Oragenics (OGEN) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $350K of Oragenics stock for Q4 2023, up 92% quarter-over-quarter.
- 0 funds opened new Oragenics positions in Q4 2023 and 0 closed out.
- The largest Oragenics buyer in Q4 2023 was Renaissance Technologies, an estimated $7.46K added.
- The largest Oragenics seller in Q4 2023 was Tower Research Capital (TRC), an estimated $4.38K sold.
Based on aggregated 13F filings for Q4 2023.